Abscopal antitumor immune effects of magnet-mediated hyperthermia at a high therapeutic temperature on Walker-256 carcinosarcomas in rats

Oncology Letters

Volumn 7, Issue 3, 2014, Pages 764-770

  Wang, Hui ^a,b   Zhang, Li ^c   Shi, Yingrui ^a   Javidiparsijani, Sara ^d   Wang, Guirong ^d   Li, Xiao ^b   Ouyang, Weiwei ^e   Zhou, Jumei ^a   Zhao, Lingyun ^b   Wang, Xiaowen ^b   Zhang, Xiaodong ^b   Gao, Fuping ^b   Liu, Jingshi ^f   Luo, Junming ^a,g   Tang, Jintian ^b  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d State University of New York Upstate Medical University: College of Medicine   (United States)

^e Guizhou Cancer Hospital   (China)

^f HUNAN CANCER HOSPITAL   (China)

^g QINGHAI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Abscopal effect; Magnet mediated hyperthermia; Temperature; Tumor immunity; Walker 256 carcinosarcoma

Indexed keywords

CYCLINE; CYTOKINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAGNET; NONHUMAN; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE SUBPOPULATION; TEMPERATURE; TUMOR GROWTH; WALKER CARCINOMA;

EID: 84892975691     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1803     Document Type: Article

References (21)

1. van der Zee J: Heating the patient: a promising approach? Ann Oncol13: 1173-1184, 2002.
2. Hildebrandt B, Wust P, Ahlers O, et al: The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol43: 33-56, 2002.
3. Moroz P, Jones SK and Gray BN: Magnetically mediated hyperthermia: current status and future directions. Int JHyperthermia18: 267-284, 2002.
4. Wang H, Li X, Xi X, Hu B, Zhao L, Liao Y and Tang J: Effects of magnetic induction hyperthermia and radiotherapy alone or combined on a murine 4T1 metastatic breast cancer model. Intl J Hyperthermia27: 563-572, 2011.
5. Camphausen K, Moses MA, Ménard C, et al: Radiation abscopal antitumor effect is mediated through p53. Cancer Res63: 1990-1993, 2003.
6. Blanquicett C, Saif MW, Buchsbaum DJ, et al: Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. Clin Cancer Res11: 8773-8781, 2005.
7. Sgouros G, Knox SJ, Joiner MC, Morgan WF and Kassis AI: MIRD continuing education: Bystander and low dose-rate effects: are these relevant to radionuclide therapy? J Nucl Med48: 1683-1691, 2007.
8. Strauss AA, Appel M, Saphir O and Rabinovitz AJ: Immunologic resistance to carcinoma produced by electrocoagulation. Surg Gynecol Obstet 121: 989-996, 1965.
9. Park BH, Koo BS, Kim YK and Kim MK: The induction of hyperthermia in rabbit liver by means of duplex stainless steel thermoseeds. Korean J Radiol3: 98-104, 2002.
10. Tucker RD: Use of interstitial temperature self-regulating thermal rods in the treatment of prostate cancer. J Endourol17: 601-607, 2003.
11. Izawa H, Hachiya Y, Kawai T, Muramatsu K, Narita Y, Ban N and Yoshizawa H: The effect of heat-treated human bone morphogenetic protein on clinical implantation. Clin Orthop Relat Res390: 252-258, 2001.
12. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L and Formenti SC: Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys58: 862-870, 2004.
13. Van der Meeren A, Monti P, Vandamme M, Squiban C, Wysocki J and Griffiths N: Abdominal radiation exposure elicits inflammatory responses and abscopal effects in the lungs of mice. Radiat Res163: 144-152, 2005.
14. Srivastava PK and Maki RG: Stress-induced proteins in immune response to cancer. Curr Top Microbiol Immunol167: 109-123, 1991.
15. Wells AD, Rai SK, Salvato MS, Band H and Malkovsky M: Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. Int Immunol10: 609-617, 1998.
16. Wells AD and Malkovsky M: Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol Today21: 129-132, 2000.
17. Ito A, Shinkai M, Honda H, Yoshikawa K, Saga S, WakabayashiT, Yoshida J and Kobayashi T: Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol Immunother52: 80-88, 2003.
18. Todryk S, Melcher AA, Hardwick N, Linardakis E, Bateman A, Colombo MP, Stoppacciaro A and Vile RG: Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol163: 1398-1408, 1999.
19. Ito A, Shinkai M, Honda H, Wakabayashi T, Yoshida J and Kobayashi T: Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother50: 515-522, 2001.
20. Dressel R, Lübbers M, Walter L, Herr W and Günther E: Enhanced susceptibility to cytotoxic T lymphocytes without increase of MHC class I antigen expression after conditional overexpression of heat shock protein 70 in target cells. Eur J Immunol 29: 3925-3935, 1999.
21. Srivastava PK, Udono H, Blachere NE and Li Z: Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39: 93-98, 1994.